Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
New Approach Will Lead to a Better Understanding of Most Cases
Read moreIcahn School of Medicine at Mount Sinai
Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug
Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure
Read moreTeaching Preschool Caregivers about Healthy Behaviors May Promote Healthier Lifestyle in Some High-Risk Groups
Study Shows Vascular Ultrasounds and Adhering to Interventional Education in Underserved Communities can Improve Health among Parents and School Staff
Read moreMount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions
A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).
Read moreHuman Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug
The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.
Read moreProstate Cancer Research Gala Recognizes Innovations in Treatment and Patient Care
Atlanta Falcons and Atlanta United owner Arthur Blank and Nina Bhardwaj, MD, PhD, will be honored for their contributions to prostate cancer research.
Read moreEye Damage Linked to Popular Over-the-Counter Vitamin That Lowers Cholesterol Can Be Reversed
Study is the first to identify specific cellular toxicity and show improvement after stopping supplement use
Read moreIcahn School of Medicine at Mount Sinai Launches First-Of-Its-Kind Diversity Innovation Hub to Use Technology to Close Gaps in Local Health Care
The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai’s Office of Diversity and Inclusion.
Read moreMount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine
A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).
Read moreArtificial Pancreas System Better Controls Blood Glucose Levels than Current Technology
Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes
Read moreTape Strips Identified as Non-Invasive Approach to Assess Skin Biomarkers in Children With Atopic Dermatitis
May also help predict therapeutic responses
Read moreOptimism Linked to Lower Risk of Cardiovascular Events and Death
Research identifies a new target for helping patients decrease risk of heart disease and promote health
Read more